- /
- Supported exchanges
- / BE
- / SYK.BE
STRYKER (SYK BE) stock market data APIs
STRYKER Financial Data Overview
There is no Profile data available for SYK.BE.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get STRYKER data using free add-ons & libraries
Get STRYKER Fundamental Data
STRYKER Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-30
- EPS/Forecast: 3.13
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
STRYKER News
New
Is Stryker Still a Good Value After 5.5% Weekly Rise and New Partnerships?
Wondering if Stryker is a bargain or priced to perfection? Here is what you need to know before making your next move. Stryker’s share price recently climbed 5.5% in the last week and is up 4.1% yea...
Is Force Feedback the Next Big Catalyst for ISRG's da Vinci Sales?
Intuitive Surgical’s ISRG latest FDA-cleared software upgrades for da Vinci 5 — Force Gauge and Focus Mode — signal a meaningful step toward real-time, data-rich surgery, and may ultimately beco...
J&J's MedTech Unit Sales Improve: Will the Momentum Last?
Johnson & Johnson's JNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech segment accounts for around 36% of J&J’...
Regenerative Medicine Market Research Report 2025 Featuring Stryker, Athersys, Integra Lifesciences, Isto Biologics, Organogenesis, CryoLife, Medtronic, U.S. Stem Cell, Zimmer Biomet, and 3M
Company Logo The regenerative medicine market offers significant opportunities in personalized stem cell therapies, driven by rising cancer cases and demand for effective chronic disease treatments. ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.